Daphne Collias, PhD

Daphne Collias, PhD has a diverse background in scientific research and industry. Daphne is currently working as a Scientist in Liver Gene Editing Therapeutic Discovery at Prime Medicine, Inc. Since 2023. Previously, they held the position of Project Leader and Sr. Postdoctoral Researcher at the Helmholtz Institute for RNA-based Infection Research (HIRI) from 2021 to 2022. In this role, they focused on commercializing a next-generation CRISPR platform technology called LEOPARD.

Before their time at HIRI, Daphne completed their PhD at North Carolina State University (NCSU) and the Helmholtz Institute for RNA-based Infection Research. Their research mainly focused on DNA targeting requirements and outcomes for CRISPR technologies. During their time at NCSU, they also led a project team, served as a teaching assistant, supervised undergraduate and Master's students, and presented their work at various conferences.

Daphne's work experience also includes being an Undergraduate Researcher at the University of Delaware, where they conducted research on gene delivery and expression in inflammatory breast cancer cells. Daphne also gained industry experience as a Summer Intern at Merck & Co., where they supported technical services for the manufacture of refrigerated products.

Additionally, Daphne has worked as a Summer Research Student at Princeton University, where they studied the degradation of a PEG layer on nanoparticles for drug delivery applications. Daphne also interned at the Office of Economic Innovation and Partnerships (OEIP) at the University of Delaware, where they played a role in protecting the university's intellectual property. Daphne conducted research on technologies, wrote summaries, and facilitated communication between potential licensees and project managers.

Daphne's early research experiences include being a SURF Student at the Cincinnati Children's Hospital Medical Center, where they learned laboratory techniques related to genotyping and blood analysis. Daphne also interned at the Institute of Electronic Structure and Laser at the University of Crete, Greece, where they studied the structure-property relationships of polymers.

Overall, Daphne Collias, PhD's work experience encompasses a range of positions in scientific research, industry, and academia, with a particular focus on CRISPR technologies and gene editing.

Daphne Collias, PhD, holds a Doctor of Philosophy (PhD) degree in Chemical and Biomolecular Engineering from North Carolina State University (2016-2020). Prior to their doctoral studies, they completed their Bachelor's degree (BCE) in Chemical and Biomolecular Engineering at the University of Delaware (2012-2016). Daphne completed their high school education at William Mason High School from 2008 to 2012, but no specific degree or field of study is mentioned.